Phibro Animal Health Corporation
PAHC
$33.26
-$0.20-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 383.54M | 373.91M | 363.89M | 378.70M | 347.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 383.54M | 373.91M | 363.89M | 378.70M | 347.83M |
| Cost of Revenue | 257.87M | 240.42M | 242.99M | 270.15M | 237.75M |
| Gross Profit | 125.68M | 133.50M | 120.90M | 108.55M | 110.07M |
| SG&A Expenses | 77.50M | 78.50M | 72.05M | 68.07M | 67.98M |
| Depreciation & Amortization | -- | -- | -- | 2.38M | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 335.37M | 318.92M | 315.04M | 340.59M | 305.73M |
| Operating Income | 48.17M | 54.99M | 48.85M | 38.10M | 42.09M |
| Income Before Tax | 32.31M | 36.43M | 36.27M | 23.85M | 29.69M |
| Income Tax Expenses | 8.29M | 8.97M | 9.74M | 6.62M | 8.81M |
| Earnings from Continuing Operations | 24.02M | 27.46M | 26.53M | 17.22M | 20.88M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.02M | 27.46M | 26.53M | 17.22M | 20.88M |
| EBIT | 48.17M | 54.99M | 48.85M | 38.10M | 42.09M |
| EBITDA | 60.62M | 67.88M | 61.68M | 49.09M | 54.71M |
| EPS Basic | 0.59 | 0.68 | 0.65 | 0.43 | 0.52 |
| Normalized Basic EPS | 0.55 | 0.63 | 0.52 | 0.44 | 0.59 |
| EPS Diluted | 0.59 | 0.67 | 0.65 | 0.43 | 0.51 |
| Normalized Diluted EPS | 0.55 | 0.63 | 0.52 | 0.43 | 0.59 |
| Average Basic Shares Outstanding | 40.55M | 40.53M | 40.53M | 40.50M | 40.52M |
| Average Diluted Shares Outstanding | 41.04M | 40.96M | 40.88M | 40.70M | 40.71M |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 20.26% | 17.71% | 18.34% | 28.24% | 23.30% |